Abstract
This paper briefly reviews the pharma-cologic effects of nonsteroidal antiinflammatory drugs (NSAIDs) that influence the risks and benefits of using these drugs prophylactically for cancer. It describes the metabolism of arachidonic acid through the cyclooxygenase (COX) pathway, the physiologic functions of prostanoids (prostag-landins, prostacyclin, and thromboxane A2) produced by this pathway, and the pharmacologic consequences of blocking the enzymatic activity of the two COX isoforms. We mention other proposed mechanisms by which NSAIDs may directly or indirectly affect non-COX pathways. The diverse pharmacologic effects of NSAIDs, when combined with the relatively low probability that an individual with average risk will develop any single type of cancer over a lifetime, severely limit the tolerance for toxicity if aspirin or related drugs are to be administered prophylactically to large numbers of otherwise healthy people. Further research is needed to identify a drug, dose, treatment regimen, and patient population(s) where the benefits of prophy- lactic treatment will exceed the risks. A singular advantage of aspirin over all other NSAIDs is the potential to combine reduced risk of certain cancers with cardiovascular benefit. However, many elements that are needed to achieve this remain unresolved.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Smyth E, Burke A, FitzGerald G (2006) Lipid-derived autacoids: eicosanoids and platelet-activating factor. In: Brunton L, Lazo J, Parker K (eds) Goodman and Gillman's the pharmacological basis of therapeutics. McGraw-Hill Companies, New York, p 653–669
Burke A, Smyth E, FitzGerald G (2006) Analgesic-antipyretic agents; pharmacotherapy of gout. In: Brunton L, Lazo J, Parker K (eds) Goodman and Gillman's the pharmacological basis of therapeutics. McGraw-Hill Companies, New York, p 671–715
Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, Lippman SM (2000) 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxyge-nase-2 in colon cancer cells. Cancer Res 60:6846–6850
Zhang Z, Dubois RN (2000) Par-4, a proap-optotic gene, is regulated by NSAIDs in human colon carcinoma cells. Gastroenterology 118:1012–1017
Zhang L, Yu J, Park BH, Kinzler K W, Vogelstein B (2000) Role of BAX in the apoptotic response to anticancer agents. Science 290:989–992
Chan TA, Morin PJ, Vogelstein B, Kinzler KW (1998) Mechanisms underlying nonsteroidal anti-inflammatory drug-mediated apoptosis. Proc Natl Acad Sci U S A 95:681–686
Bellosillo B, Piqué M, Barragán M, Castaño E, Villamor N, Colomer D, Montserrat E, Pons G, Gil J (1998) Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 92:1406–1414
Schwenger P, Alpert D, Skolnik E Y, Vilcek J (1998) Activation of p38 mitogen activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IκBa phosphorylation and degradation. Mol Cell Biol 18:78–84
Zimmermann KC, Waterhouse NJ, Goldstein JC, Schuler M, Green DR (2000) Aspirin induces apoptosis through release of cytochrome c from mitochondria. Neoplasia 2:505–513
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Thun, M.J., Blackard, B. (2009). Pharmacologic Effects of NSAIDs and Implications for the Risks and Benefits of Long-Term Prophylactic Use of Aspirin to Prevent Cancer. In: Senn, HJ., Kapp, U., Otto, F. (eds) Cancer Prevention II. Recent Results in Cancer Research, vol 181. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69297-3_20
Download citation
DOI: https://doi.org/10.1007/978-3-540-69297-3_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-69296-6
Online ISBN: 978-3-540-69297-3
eBook Packages: MedicineMedicine (R0)